Fractionated Therapy of HER2-Expressing Breast and Ovarian Cancer Xenografts in Mice with Targeted Alpha Emitting 227Th-DOTA-p-benzyl-trastuzumab

Helèn Heyerdahl(Nordic Nanovector (Norway)), Jostein Dahle(Oslo University Hospital), Camilla Mollatt(Oslo University Hospital), Nasir Abbas, Ellen Mengshoel Brevik

PLoS ONE

August 3, 2012

10.1371/journal.pone.0042345

Cited by 63

Related Papers

Global, regional, and national prevalence of adult overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021

|The Lancet|2025|966

Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023

|The Lancet|2025|589

DISTRIBUTION OF 5‐AMINOLEVULINIC ACID‐INDUCED PORPHYRINS IN NODULOULCERATIVE BASAL CELL CARCINOMA

|Photochemistry and Photobiology|1995|181

Global, regional, and national sepsis incidence and mortality, 1990–2021: a systematic analysis

|The Lancet Global Health|2025|154

Global age-sex-specific all-cause mortality and life expectancy estimates for 204 countries and territories and 660 subnational locations, 1950–2023: a demographic analysis for the Global Burden of Disease Study 2023

|The Lancet|2025|139